Market Tracker

02/24 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2379
Delayed Data
As of Feb 24
 +0.0029 / +1.23%
Today’s Change
0.13
Today|||52-Week Range
0.41
+67.65%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.24
Today’s open0.24
Day’s range0.23 - 0.25
Volume1,456,508
Average volume (3 months)1,795,266
Market cap$56.5M
Dividend yield--
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)+12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
NBYNovaBay Pharmaceutic...-0.13-3.18%
NTECIntec Pharma Ltd+0.05+1.05%
DRNADicerna Pharmaceutic...+0.06+2.20%
RGLSRegulus Therapeutics...+0.05+4.76%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts